Hubei Jianxiang Bioscience: difference between revisions
Diff·revision 16 → 17·19:06, 17 Nov 2025
Difference between revision 16 and revision 17 of Hubei Jianxiang Bioscience. 7 lines changed; the page grew by 1,005 bytes.
| Revision 16 — 10:55, 29 Oct 2025 PrimarySrcPatia (talk) add the transit window each regional warehouse serves 12,055 bytes +2,041 | Revision 17 — 19:06, 17 Nov 2025 Ref_Desk_Ron (talk) add the outbound storefront link, marked nofollow and sponsored per the external-links convention 13,060 bytes +1,005 | ||
|---|---|---|---|
| 85 | * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} | 85 | * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} |
| 86 | 86 | ||
| + | 87 | PeptidePedia does not rank suppliers and does not maintain a league table. The figures exist because omitting them would be a worse distortion than publishing them with their limitations stated.{{r|tally}} | |
| + | 88 | ||
| 87 | == Regulatory position and legal status == | 89 | == Regulatory position and legal status == |
| 88 | The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.{{r|registry}} | 90 | The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.{{r|registry}} |
| 89 | 91 | ||
| 90 | Material labelled [[Research use only|for research use only]] is outside the regulatory framework that governs medicines. Its identity, purity, sterility and [[Bacterial endotoxin test|endotoxin]] content are not assured by any regulator, and a [[Certificate of analysis|certificate of analysis]] issued by a supplier is a claim by that supplier rather than an independent finding.{{r|ruo,usp1503}} | 92 | Material labelled [[Research use only|for research use only]] is outside the regulatory framework that governs medicines. Its identity, purity, sterility and [[Bacterial endotoxin test|endotoxin]] content are not assured by any regulator, and a [[Certificate of analysis|certificate of analysis]] issued by a supplier is a claim by that supplier rather than an independent finding.{{r|ruo,usp1503}} |
| + | 93 | ||
| + | 94 | == Notability and coverage == | |
| + | 95 | This article exists because the organisation satisfies at least three of the five criteria at [[Project:Vendor notability]]. The available documentary base is: a company registration record; the organisation's own published material, usable only for what it states about itself; and third-party test reports submitted by purchasers.{{r|registry,selfpub,reports}} | |
| + | 96 | ||
| + | 97 | What is '''not''' available is independent coverage in a source unconnected with the organisation or its customers. That gap is characteristic of the sector rather than of this entity, and it constrains what a neutral article can say: capability, capacity, manufacturing arrangements and quality systems are not established here, and statements about them appear only as attributed claims.{{r|selfpub}} | |
| 91 | 98 | ||
| 92 | == References == | 99 | == References == |